Thank you for your cooperation. (The degraded operation period has changed.
smoking, tobacco cessation, Nicotine replacement therapy or NRT, tobacco use, tobacco prevalence, cigarette smoking
Alzheimer Disease and Associated Disorders is a leading international forum for reports of new research findings and new approaches to diagnosis and treatment. Contributions fall within all relevant scientific fields and clinical specialties, including neurobiology, neurochemistry, molecular biology, neurology, neuropathology, neuropsychology, psychiatry, gerontology, and geriatrics. Rigorous peer review of articles is ensured by an international Editorial Advisory Board of eminent scientists and clinicians. Website: www.alzheimerjournal.com.
Neuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG) , provides a forum for experimental and clinical investigations of the genetic mechanisms underlying neurologic and psychiatric disorders. It is a resource for novel genetics studies of the heritable nature of psychiatric and other nervous system disorders, characterized at the molecular, cellular or behavior levels. Neuropsychiatric Genetics publishes eight times per year.
The Annual Review of Clinical Psychology, in publication since 2005, provides comprehensive reviews of significant developments in the field of Clinical Psychology and Psychiatry. The journal covers research, theory, and the application of psychological principles to address recognized disorders, including schizophrenia, mood, anxiety, childhood, substance use, cognitive, and personality disorders. Chapters also address broader issues cross-cutting the field, such as diagnosis, treatment, social policy, and cross-cultural and legal issues.
Clinical Case Studies (CCS) is the only journal devoted entirely to case studies. It presents cases involving individual, couples, and family therapy. The easy-to-follow case presentation format allows you to learn how interesting and challenging cases were assessed and conceptualized, and how treatment followed such conceptualization. This practical format allows clinicians to replicate successful treatments in their own practices. Cases follow a 12-point format.
Depression and Anxiety welcomes original research and synthetic review articles covering molecular, genetic, biopsychosocial, neurochemical, neuropsychological, physiological, behavioral, sociological, psychodynamic, psychotherapeutic, cognitive and pharmacotherapeutic aspects of mood and anxiety disorders and related phenomena in humans and animals. The journal publishes full-length Research Papers, Topical Reviews, Brief Reports, Book Reports, Clinical Case Studies, and Letters. Contributions are grouped and published by topic.
International Clinical Psychopharmacology continues to maintain its high standing in publication of research and clinical practice within the field of psychopharmacology. This respected journal is largely concerned with psychotropic drugs, covering phase I-IV studies, clinical studies, side-effects and epidemiology. Papers deal with studies on both healthy volunteers and patients. Regular volume indexes make the journal an invaluable reference in the field. For more information, visit www.intclinpsychopharm.com.
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
This leading publication in psychopharmacology offers a wide range of articles that report on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, medico-legal issues, and psychiatric effects of non-psychiatric drugs. The Journal keeps psychiatrists and psychiatric residents up-to-date on the latest clinical developments in the psychotropics, presenting the extensive coverage needed to keep up with every development in this fast-growing field. For more information, visit www.psychopharmacology.com.